Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Targeted cancer therapies require precise identification of cancer vulnerabilities.
• MicroRNA (miRNA) expression patterns can be altered by pathway activation in cancer cells.

Purpose of the Study:

• To develop and validate a novel approach for identifying druggable cancer targets by analyzing miRNA expression signatures.
• To assess the utility of this approach in predicting therapeutic strategies across diverse cancer types.

Main Methods:

• Utilized small RNA sequencing to analyze miRNA expression in response to pathway activation.
• Developed a computational approach integrating low-miRNA-expression signatures to identify potential drug targets.
• Validated the approach in colorectal cancer models and extended it to patient-derived in vitro and in vivo systems.

Main Results:

• Discovered that miRNAs inhibiting activated pathways are often underexpressed in cancer.
• The developed approach successfully identified druggable target genes in various cancer models.
• Demonstrated the approach's value in supporting genomic and transcriptomic drug prediction strategies in a precision oncology trial.

Conclusions:

• The novel strategy accurately predicts cancer vulnerabilities and potential therapeutic targets.
• This approach shows promise for guiding personalized therapy recommendations in multiple cancer subtypes.
• Integration of miRNA expression signatures offers a sensitive and accurate method for cancer target identification.